Status:
UNKNOWN
Combined Exercise and Nutrition Intervention for Possible Sarcopenia Among Older Adults in Primary Care
Lead Sponsor:
Kyunghee University Medical Center
Conditions:
Sarcopenia
Eligibility:
All Genders
65-85 years
Phase:
NA
Brief Summary
The purpose of this study is to assess the impact of a combined exercise-nutrition intervention in primary clinics on sarcopenia indices, physical function, and quality of life in community-dwelling o...
Detailed Description
This study will investigate the effects of a 12-week combined exercise-nutrition intervention by comparing it with a control group receiving standard care (usual care) by assessing the sarcopenia indi...
Eligibility Criteria
Inclusion
- 65 to 85 years of age
- Men and women with possible sarcopenia
- If included in the possible sarcopenia criteria in the 2019 Asian Working Group for Sarcopenia(AWGS) criteria A Simple Questionnaire to Rapidly Diagnose Sarcopenia(The Korean SARC-F questionnaire) score is 4 or higher; or Calf circumference (Men's: \<34 cm, Women's: \<33 cm) + Decreased muscle strength (male: \<28kg, female: \<18kg) or Decreased physical function (if it takes more than 12 seconds from the 5-chair stand test)
- \[(1) and {(2) or (3)}\]
Exclusion
- Renal failure: Serum creatine exceeding 2.0 mg/dl
- Uncontrolled hypertension: systolic/diastolic blood pressure greater than 150/90 millimeter of mercury(mmHg)
- Uncontrolled diabetes: glycated hemoglobin (HbA1C) over 7.5%
- Subject who are receiving treatment (steroids, anticancer drugs, etc.) that can affect muscle mass
- Subjects with myocardial infarction or angina pectoris, stroke disease
- Malignant tumor: Subject who has a history of cancer within 5 years or is currently receiving treatment
- Subjects who have liver cirrhosis and uncontrolled hepatitis (Aspartate aminotransferase or Alanine aminotransferase is more than three times the upper limit of the reference range)
- Subjects who have chronic diseases such as musculoskeletal disorders that are impossible to exercise
- Subjects who are allergic to soybeans, coix, and brown rice
Key Trial Info
Start Date :
August 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06049914
Start Date
August 8 2023
End Date
December 31 2024
Last Update
September 22 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongdong Family Medicine Clinic
Dobong, Seoul, South Korea, 01384
2
Dongbu-hanil Surgery Clinic
Dobong, Seoul, South Korea
3
Seoulbom United Clinic
Dobong, Seoul, South Korea